Literature DB >> 21197120

Health conditions associated with aging and end of life of adults with Down syndrome.

Anna J Esbensen1.   

Abstract

Expectations for the life course of individuals with Down syndrome (DS) have changed, with life expectancy estimates increasing from 12 in 1949 to nearly 60 years of age today (Bittles & Glasson, 2004; Penrose, 1949). Along with this longer life expectancy comes a larger population of adults with DS who display premature age-related changes in their health. There is thus a need to provide specialized health care to this aging population of adults with DS who are at high risk for some conditions and at lower risk for others. This review focuses on the rates and contributing factors to medical conditions that are common in adults with DS or that show changes with age. The review of medical conditions includes the increased risk for skin and hair changes, early onset menopause, visual and hearing impairments, adult onset seizure disorder, thyroid dysfunction, diabetes, obesity, sleep apnea and musculoskeletal problems. The different pattern of conditions associated with the mortality of adults with DS is also reviewed.

Entities:  

Year:  2010        PMID: 21197120      PMCID: PMC3010180          DOI: 10.1016/S0074-7750(10)39004-5

Source DB:  PubMed          Journal:  Int Rev Res Ment Retard        ISSN: 0074-7750


  102 in total

1.  Age at onset of dementia and age of menopause in women with Down's syndrome.

Authors:  M P Cosgrave; J Tyrrell; M McCarron; M Gill; B A Lawlor
Journal:  J Intellect Disabil Res       Date:  1999-12

Review 2.  Aging and Down syndrome: implications for physical therapy.

Authors:  Robert C Barnhart; Barbara Connolly
Journal:  Phys Ther       Date:  2007-08-21

3.  Visual defects in cases of Down's syndrome and in other mentally handicapped children.

Authors:  P A Gardiner
Journal:  Br J Ophthalmol       Date:  1967-07       Impact factor: 4.638

4.  Risks of leukaemia and solid tumours in individuals with Down's syndrome.

Authors:  H Hasle; I H Clemmensen; M Mikkelsen
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

5.  Prevalence of cataract and pseudophakia/aphakia among adults in the United States.

Authors:  Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor
Journal:  Arch Ophthalmol       Date:  2004-04

6.  Prevalence of overweight and obesity in Down's syndrome and other mentally handicapped adults living in the community.

Authors:  A J Bell; M S Bhate
Journal:  J Intellect Disabil Res       Date:  1992-08

7.  Overweight and obesity amongst Down's syndrome adults.

Authors:  V P Prasher
Journal:  J Intellect Disabil Res       Date:  1995-10

8.  Obstructive sleep apnea in children with Down syndrome.

Authors:  C L Marcus; T G Keens; D B Bautista; W S von Pechmann; S L Ward
Journal:  Pediatrics       Date:  1991-07       Impact factor: 7.124

9.  Epilepsy in Down syndrome--prevalence in three age groups.

Authors:  P Johannsen; J E Christensen; H Goldstein; V K Nielsen; J Mai
Journal:  Seizure       Date:  1996-06       Impact factor: 3.184

10.  Lower cervical spondylosis and myelopathy in adults with Down's syndrome.

Authors:  P M Olive; T S Whitecloud; J T Bennett
Journal:  Spine (Phila Pa 1976)       Date:  1988-07       Impact factor: 3.468

View more
  49 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  Event-related potential index of age-related differences in memory processes in adults with Down syndrome.

Authors:  Alexandra P Key; Elisabeth M Dykens
Journal:  Neurobiol Aging       Date:  2013-08-29       Impact factor: 4.673

3.  Using machine learning to identify patterns of lifetime health problems in decedents with autism spectrum disorder.

Authors:  Lauren Bishop-Fitzpatrick; Arezoo Movaghar; Jan S Greenberg; David Page; Leann S DaWalt; Murray H Brilliant; Marsha R Mailick
Journal:  Autism Res       Date:  2018-05-07       Impact factor: 5.216

4.  Stem cells: Down's syndrome link to ageing.

Authors:  George P Souroullas; Norman E Sharpless
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

5.  Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

Authors:  Mireia Vilardell; Axel Rasche; Anja Thormann; Elisabeth Maschke-Dutz; Luis A Pérez-Jurado; Hans Lehrach; Ralf Herwig
Journal:  BMC Genomics       Date:  2011-05-11       Impact factor: 3.969

Review 6.  Medicine in stamps: history of Down syndrome through philately.

Authors:  Ahmet Doğan Ataman; Emine Elif Vatanoğlu-Lutz; Gazi Yıldırım
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

7.  Anesthetic Management of a Down Syndrome Patient with Subocclusive Syndrome.

Authors:  George Gabriel Moldoveanu; Emilia Severin; Andreea Paun
Journal:  Maedica (Buchar)       Date:  2018-06

8.  "Intellectual developmental disorders": reflections on the international consensus document for redefining "mental retardation-intellectual disability" in ICD-11.

Authors:  Marco O Bertelli; Kerim Munir; James Harris; Luis Salvador-Carulla
Journal:  Adv Ment Health Intellect Disabil       Date:  2016

9.  CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  Hippocampus       Date:  2018-02-12       Impact factor: 3.899

10.  Adaptive downregulation of mitochondrial function in down syndrome.

Authors:  Pablo Helguera; Jaqueline Seiglie; Jose Rodriguez; Michael Hanna; Gustavo Helguera; Jorge Busciglio
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.